Children with Cancer UK is the leading UK charity dedicated to the fight against childhood cancer. We are delighted to announce that our annual conference Childhood Cancer 2019 will be hosted by Newcastle University on 9-10th September 2019.
Chaired by Professor Steve Clifford of Newcastle University and Dr Nick Goulden on behalf of Children with Cancer UK, key areas to be discussed in the meeting include:
100k genome GECIPS SMPaeds & INSTINCT Phase I/II networks
Speakers: Professors Steve Clifford, Adrienne Flannagan, Anthony Moorman, Darren Hargrave & Dr Lynley Marshall
Brain Tumours, Neuroblastoma, Lymphoma
Speakers: Professor Chris Jones, Dr Sally George, Dr Simon Bomken
CAR- T in Solid Tumours & Leukaemia, Senescence
Speakers: include Dr Karin Straathof and Dr Sara Ghorashian
QOL in Brain Tumours, Scope for prospective intervention
Speakers: include Dr Rod Skinner, Dr Sara Watts
AML in Down syndrome , circulating DNA, NGS for detection of MRD
Speakers: include Dr John Moppett
Update from Childhood Cancer 2018, Children with Cancer UK causation grant round
Speakers: Trustee Alasdair Philips, Professor Denis Henshaw
Speakers: include Professor Simon Bailey, Dr Vikki Rand
Evolution of Cancer Genetics, Professor Christine Harrison Newcastle University
Childhood Cancer 2019: Exploiting genomic medicine throughout the patient journey
Day 1 – Monday 9th September 2019
Day 2 – Tuesday 10th September 2019
We invite the submission of abstracts of poster presentations on the conference theme namely
”Exploiting genomic medicine throughout the patient journey”.
All presentations must be relevant to paediatric and TYA oncology and malignant haematology.
IMPORTANT: Authors of submitted and accepted poster abstracts please note:
The submission deadline for abstracts is 17.00 on 22nd July 2019
Professor Steven Clifford BSc, PhD(Cancer Molecular Biology)
Professor of Molecular Paediatric Oncology and Director, Northern Institute for Cancer Research, Newcastle University.
Professor Clifford’s research is focussed on understanding the biological basis of embryonal brain tumour development (principally medulloblastoma) and response to therapy, and translating these findings into improved clinical treatments. He plays leading roles in national (CCLG, NCRI) and international (SIOP-Europe) research networks and clinical trials in medulloblastoma, and directs the UK national reference centre for medulloblastoma molecular diagnostics.
Professor Anthony Moorman, BSc, MSc, PhD (Epidemiology)
Professor of Genetic Epidemiology, Northern Institute for Cancer Research, Newcastle University.
Anthony Moorman has worked in the field of leukaemia genetics for more than 25 years and, along with the other members of the Leukaemia Research Cytogenetics Group (LRCG), has been involved in the discovery, characterisation and clinical assessment of numerous genetic biomarkers in acute lymphoblastic and myeloid leukaemia. More recently, Anthony’s research has focussed on integrating risk factors to assist the design of novel risk stratification algorithms.
Dr Nick Goulden MB, ChB, MRCP, FRCPath, PhD
Medical Research Director, Children with Cancer UK.
Nick Goulden retired from Great Ormond Street Hospital, where he was a Consultant in Paediatric Haematologyin December 2015. He subsequently took up the role of Medical Research Director at Children with Cancer UK on a consultancy basis.Nick was instrumental in incorporating the detection of minimal residual disease (MRD) into treatment stratification for childhood acute lymphoblastic leukaemia (ALL).
To purchase your ticket for the conference, please fill in your details below.